Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis

International Journal of Infectious Diseases

Volumn 14, Issue SUPPL. 3, 2010, Pages

  Tutuncu, E Ediz ^a   Kuscu, Ferit ^a   Gurbuz, Yunus ^a   Ozturk, Baris ^a   Haykir, Asli ^a   Sencan, Irfan ^a  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Acinetobacter baumannii; Meningitis; Multidrug resistance; Tigecycline

Indexed keywords

MEROPENEM; NETILMICIN; TIGECYCLINE; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADULT; ARTICLE; BACTERIUM CULTURE; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; FOLLOW UP; HUMAN; LOADING DRUG DOSE; LUMBAR PUNCTURE; MALE; MENINGITIS; MULTIDRUG RESISTANCE; NONHUMAN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; MINOCYCLINE; NEUROSURGICAL PROCEDURES; SURGICAL WOUND INFECTION;

EID: 77957350651     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2009.07.022     Document Type: Article

References (18)

1. Bergogne-Berezin E., Towner K.J. Acinetobacter spp as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996, 9:148-165.
2. Krol V., Hamid N.S., Cunha B.A. Neurosurgically related nosocomial Acinetobacter baumannii meningitis: report of two cases and literature review. J Hosp Infect 2009, 71:176-180.
3. Metan G., Alp E., Aygen B., Sumerkan B. Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance. J Antimicrob Chemother 2007, 60:197-199.
4. Wroblewska M.M., Dijkshoorn L., Marchel H., van den Barselaar M., Swoboda-Kopec E., van den Broek P.J., et al. Outbreak of nosocomial meningitis caused by Acinetobacter baumannii in neurosurgical patients. J Hosp Infect 2004, 57:300-307.
5. Wang K.W., Chang W.N., Huang C.R., Tsai N.W., Tsui H.W., Wang H.C., et al. Post-neurosurgical nosocomial bacterial meningitis in adults: microbiology, clinical features, and outcomes. J Clin Neurosci 2005, 12:647-650.
6. Palabiyikoglu I., Tekeli E., Cokca F., Akan O., Unal N., Erberktas I., et al. Nosocomial meningitis in a university hospital between 1993 and 2002. J Hosp Infect 2006, 62:94-97.
7. Metan G., Alp E., Aygen B., Sumerkan B. Carbapenem resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis. Int J Antimicrob Agents 2007, 29:112-113.
8. O'Neill E., Humphreys H., Phillips J., Smyth E.G. Third generation cephalosporin resistance among Gram-negative bacilli causing meningitis in neurosurgical patients: significant challenges in ensuring effective antibiotic therapy. J Antimicrob Chemother 2006, 57:356-359.
9. Tunkel A.R., Hartman B.J., Kaplan S.L., Kaufman B.A., Roos K.L., Scheld W.M., et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004, 39:1267-1284.
10. Karageorgopoulos D.E., Falagas M.E. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008, 8:751-762.
11. Ho Y.H., Wang L.S., Chao H.J., Chang K.C., Su C.F. Successful treatment of meningitis caused by multidrug resistant Acinetobacter baumannii with intravenous and intrathecal colistin. J Microbiol Immunol Infect 2007, 40:537-540.
12. Rodriguez Guardado A., Blanco A., Asensi V., Perez F., Rial J.C., Pintado V., et al. Multidrug resistant Acinetobacter meningitis in neurosurgical patients with intravascular catheters: assessment of different treatments. J Antimicrob Chemother 2008, 61:908-913.
13. Song J.Y., Kee S.Y., Hwang I.S., Seo Y.B., Jeong H.W., Kim W.J., et al. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 2007, 60:317-322.
14. Karageorgopoulos D.E., Kelesidis T., Kelesidis I., Falagas M.E. Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence. J Antimicrob Chemother 2008, 62:44-55.
15. Wadi J.A., Al Rub M.A. Multidrug resistant Acinetobacter nosocomial meningitis treated successfully with parenteral tigecycline. Ann Saudi Med 2007, 27:456-458.
16. Gordon N.C., Wareham D.W. A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline. J Antimicrob Chemother 2009, 63:775-780.
17. Fang GD, Weiss WJ, Scheld WM. Comparative efficacy of GAR-936, a novel glycylcycline alone and in combination with vancomycin against highly penicillin-resistant Streptococcus pneumoniae experimental meningitis in rabbits. Abstract 868. Program and abstracts of the 40th Interscience Conference on Antimicrobials and Chemotherapy (ICAAC), September 17-20, 2000, Toronto, Ontario, Canada. Washington, DC: ASM Press; 2000, p. 51.
18. Entenza J.M., Moreillon P. Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies. Int J Antimicrob Agents 2009, 34:8. e1-9.